Vaso Operating Expenses 2010-2024 | VASO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$202.3B
Intuitive Surgical (ISRG)	$191.3B
Edwards Lifesciences (EW)	$44.5B
Alcon (ALC)	$42.5B
IQVIA Holdings (IQV)	$36.3B
IDEXX Laboratories (IDXX)	$33.9B
DexCom (DXCM)	$31.3B
Waters (WAT)	$22.2B
STERIS (STE)	$20.6B
SONOVA HOLDING (SONVY)	$19.8B
Hologic (HOLX)	$16.5B
Fresenius Medical Care AG KGaA (FMS)	$13.3B
Sysmex ADR (SSMXY)	$11.7B
Globus Medical (GMED)	$11.4B
Penumbra (PEN)	$9.2B
Masimo (MASI)	$9B
Glaukos (GKOS)	$8.3B
Teleflex (TFX)	$8.2B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$4.4B
Veracyte (VCYT)	$3.2B
Inari Medical (NARI)	$3.1B
LivaNova (LIVN)	$2.5B
Tandem Diabetes Care (TNDM)	$2.4B
Nihon Kohden (NHNKY)	$2.4B
TransMedics (TMDX)	$2.1B
Elekta AB (EKTAY)	$2B
Integra LifeSciences Holdings (IART)	$1.7B
RxSight (RXST)	$1.4B
Alphatec Holdings (ATEC)	$1.3B